PREGNANCY: Fenofibrate is classified as pregnancy category C. Use of fenofibrate in pregnant females has not been adequately evaluated. Fenofibrate should be avoided during pregnancy unless the benefits justify the potential risk to the fetus.
NURSING MOTHERS: Fenofibrate should not be used in nursing mothers; however, it is unknown whether fenofibrate is excreted into breast milk.
SIDE EFFECTS: Common adverse effects of fenofibrate are abnormal liver tests including AST and ALT, and headache. Less common side effects are high blood pressure, dizziness, itching, nausea, upset stomach (dyspepsia), constipation, diarrhea, urinary tract infections, flu (influenza), muscle pain, kidney problems, and respiratory tract infections.
FDA Prescribing Informaiton.
UpToDate. Lipid lowering with fibric acid derivatives.
Quick GuideLower Your Cholesterol, Save Your Heart
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.